BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2129644)

  • 21. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
    Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
    Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
    Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
    Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine.
    Bolin TD; Davis AE; Billington B
    J Clin Gastroenterol; 1987 Jun; 9(3):310-3. PubMed ID: 3302004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dose comparative study with ranitidine in the therapy and prevention of duodenal ulcer].
    Paul F; Neuhaus H; Homann J; Kamenisch W; Eimiller A
    Z Gastroenterol; 1986 Mar; 24(3):141-8. PubMed ID: 3085363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.
    Jensen DM; Cheng S; Kovacs TO; Randall G; Jensen ME; Reedy T; Frankl H; Machicado G; Smith J; Silpa M
    N Engl J Med; 1994 Feb; 330(6):382-6. PubMed ID: 8284002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of long-term maintenance therapy of duodenal ulcers.
    Penston J; Wormsley KG
    Scand J Gastroenterol; 1989 Nov; 24(9):1145-52. PubMed ID: 2595277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
    Reynolds JC; Schoen RE; Maislin G; Zangari GG
    Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intermittent treatment or preventive treatment of recurrence in duodenal ulcer disease? A controlled, double-blind study with 150 mg ranitidine daily for one year].
    Mignon M; Ruszniewski P; Pappo M; Alberola B; Georges D
    Gastroenterol Clin Biol; 1990; 14(10):732-8. PubMed ID: 2262119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The recurrence of duodenal ulcer in patients undergoing treatment with ranitidine and placebo. A multicenter study].
    Villalobos JJ; Nava AA; Elizondo J; Gallo S; Guerrero C; Vargas F; Barrera A; Centeno F; Marín E; Peña F
    Rev Gastroenterol Mex; 1991; 56(2):65-9. PubMed ID: 1947617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine.
    Penston JG; Dixon JS; Boyd EJ; Wormsley KG
    Aliment Pharmacol Ther; 1993 Jun; 7(3):259-65. PubMed ID: 8364131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year maintenance treatment with ranitidine: effects on the natural history of duodenal ulcer disease.
    Susi D; Neri M; Ballone E; Mezzetti A; Cuccurullo F
    Am J Gastroenterol; 1994 Jan; 89(1):26-32. PubMed ID: 8273793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers.
    Bank S; Greenberg RE; Magier D; Lavin PT
    Clin Ther; 1991; 13(2):304-18. PubMed ID: 1863945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research.
    Glise H; Martinson J; Solhaug JH; Carling L; Unge P; Engström G; Hallerbäck B
    Scand J Gastroenterol; 1991 Feb; 26(2):137-45. PubMed ID: 2011700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of age with the efficacy and safety of ranitidine and cimetidine in acute duodenal ulcer disease.
    Dixon JS; Mills JG; Ehsanullah RS; Wood JR
    Age Ageing; 1993 Nov; 22(6):411-8. PubMed ID: 8310886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of low-dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence.
    Bardhan KD; Morris P; Hinchliffe RF; Saunders JH; MacDougall BR; Bold JM; Freeman PR
    Aliment Pharmacol Ther; 1989 Oct; 3(5):489-97. PubMed ID: 2518862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ranitidine, cimetidine and placebo in the short and longer term treatment of duodenal ulcer].
    Klinger J; Maggiolo P; Goić A
    Rev Med Chil; 1984 Apr; 112(4):337-41. PubMed ID: 6091211
    [No Abstract]   [Full Text] [Related]  

  • 37. Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group.
    Graham DY; Colon-Pagan J; Morse RS; Johnson TL; Walsh JH; McCullough AJ; Marks JW; Sklar M; Stone RC; Cagliola AJ
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1289-94. PubMed ID: 1551535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of long-term maintenance treatment of duodenal ulcers with ranitidine.
    Penston JG
    Scand J Gastroenterol Suppl; 1990; 177():1-103. PubMed ID: 2263887
    [No Abstract]   [Full Text] [Related]  

  • 39. Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer.
    Silvis SE
    J Clin Gastroenterol; 1985 Dec; 7(6):482-7. PubMed ID: 3910710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of Helicobacter pylori infection and the recurrence of duodenal ulcers.
    Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
    J Formos Med Assoc; 1993 Aug; 92(8):721-4. PubMed ID: 7904847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.